Which has the lower trailing P/E, APO or EHC?

EHC has the lower trailing P/E: APO trades at 28.85 and EHC at 19.82. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, APO or EHC?

Over the past five years, APO grew revenue faster — APO at a 43.10% CAGR versus EHC at 4.81%.

Does APO or EHC pay a bigger dividend?

APO yields 1.68% and EHC yields 0.63% based on trailing dividends and the latest price.

Is APO or EHC more profitable?

EHC runs the higher net margin — APO at 5.22% versus EHC at 10.01%.

How have APO and EHC total returns compared?

Over the past 10 years, APO delivered 26.21% and EHC delivered 15.73% annualized total return. Past performance doesn't predict future results.

Apollo Global Management, Inc. (APO) vs Encompass Health Corporation (EHC)

A side-by-side comparison of Apollo Global Management, Inc. and Encompass Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

Different business models: APO is classified in Financial Services; EHC is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

APO

Apollo Global Management, Inc.

$74.29B

$128.98Financial ServicesDelayed quote: Sep 11, 2026, 4:00 PM EDT

EHC

Encompass Health Corporation

$12.07B

$121.71HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — APO vs EHC

growth of $100 · dividends reinvested · last 10y

APO +909.5% (+26.0%/yr)EHC +324.8% (+15.6%/yr)APO compounded faster over this window

APO EHC

APO vs EHC: by the numbers

•APO is the larger company ($74.29B vs $12.07B market cap).
•EHC trades at the lower trailing earnings multiple (19.82 vs 28.85 P/E), one valuation lens rather than an overall verdict.
•EHC converts more revenue to profit (10.01% vs 5.22% net margin).
•APO grew revenue faster over the past five years (43.10% vs 4.81% CAGR).
•APO pays the higher dividend yield (1.68% vs 0.63%).

Metrics side by side

Valuation

Metric	APO	EHC
P/E ratio	28.85	19.82
Forward P/E	14.71	19.91
P/S ratio	2.07	1.95
P/B ratio	3.54	4.65
EV / EBITDA	N/A	10.12
FCF yield	N/A	3.42%

Profitability

Metric	APO	EHC
Gross margin	95.50%	95.71%
Operating margin	24.13%	18.00%
Net margin	5.22%	10.01%
ROE	8.93%	23.91%
ROIC	N/A	13.42%

Dividends

Metric	APO	EHC
Dividend yield	1.68%	0.63%
Payout ratio	47.99%	12.38%

Growth (annualized)

Metric	APO	EHC
Revenue CAGR (5Y)	43.10%	4.81%
EPS CAGR (5Y)	66.21%	14.39%
FCF CAGR (5Y)	N/A	0.28%
Total return CAGR (5Y)	18.36%	15.18%

Frequently asked

Which has the lower trailing P/E, APO or EHC?: EHC has the lower trailing P/E: APO trades at 28.85 and EHC at 19.82. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, APO or EHC?: Over the past five years, APO grew revenue faster — APO at a 43.10% CAGR versus EHC at 4.81%.
Does APO or EHC pay a bigger dividend?: APO yields 1.68% and EHC yields 0.63% based on trailing dividends and the latest price.
Is APO or EHC more profitable?: EHC runs the higher net margin — APO at 5.22% versus EHC at 10.01%.
How have APO and EHC total returns compared?: Over the past 10 years, APO delivered 26.21% and EHC delivered 15.73% annualized total return. Past performance doesn't predict future results.

Go deeper

Full APO analysis Full EHC analysis Interactive comparison tool

Dig into the metrics

Apollo Global Management P/E ratio Encompass Health P/E ratio Apollo Global Management dividend yield Encompass Health dividend yield Apollo Global Management ROE Encompass Health ROE Apollo Global Management operating margin Encompass Health operating margin Apollo Global Management revenue growth Encompass Health revenue growth Encompass Health free cash flow

Apollo Global Management & Encompass Health appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.